Cargando…
FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights
Immunostimulating staphylococcal enterotoxin B (SEB) and related superantigenic toxins cause diseases in human beings and laboratory animals by hyperactivating cells of the immune system. These protein toxins bind to the major histocompatibility complex class II (MHC II) molecules and specific Vβ re...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423536/ https://www.ncbi.nlm.nih.gov/pubmed/28497030 http://dx.doi.org/10.2147/ITT.S125429 |